Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English
News18 » Business
1-min read

Ipca Lab Shares End Over 8% Lower as USFDA Bans Drug Import

Shares of Ipca Laboratories slumped over 8 percent on Friday after almost all drugs manufactured at its facilities at Pithampur, Silvassa and Ratlam were banned by the USFDA.

PTI

Updated:June 16, 2017, 5:01 PM IST
facebookTwitterskypewhatsapp
Ipca Lab Shares End Over 8% Lower as USFDA Bans Drug Import
Image for representation.

New Delhi: Shares of Ipca Laboratories slumped over 8 percent on Friday after almost all drugs manufactured at its facilities at Pithampur, Silvassa and Ratlam were banned by the USFDA.

The stock tanked 8.08 percent to settle at Rs 471.70 on BSE. During the day, it tumbled 14.83 percent to Rs 437. At NSE, shares of the company dived 8.12 percent to close at Rs 473.30.

The company's market valuation fell by Rs 523.51 crore to Rs 5,951.49 crore.

In terms of volume, 8.61 lakh shares of the company were traded on BSE and over 75 lakh shares changed hands at NSE during the day.

The US Food and Drug Administration (USFDA) cited violation of current good manufacturing norms for its action. The USFDA has refused admission to all drugs made at the company's Pithampur and Silvassa facility, Ipca Laboratories said in a BSE filing on Thursday.

All drugs except API Chloroquine Phosphate made at Ratlam (Madhya Pradesh) unit have also been denied entry in the US, it further said.

The ban on all drugs made at Pithampur (Madhya Pradesh) and Silvassa (Dadra and Nagar Haveli) will continue "until the company can demonstrate that the drugs manufactured from these manufacturing sites and intended for the US market are in compliance with CGMP," Ipca Laboratories added.

However, it said the US health regulator will reconsider the exception for Chloroquine Phosphate made at the Ratlam facility if shortage and/or medical necessity implications change.

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

| Edited by: Bijaya Das
Read full article
Next Story
Next Story

Also Watch

facebookTwitterskypewhatsapp
Most Active
Company Price Change %Gain
TCS 1,986.85 -0.88
Indiabulls Hsg 209.90 7.45
Infosys 814.80 4.05
IndusInd Bank 1,223.20 -0.43
Yes Bank 39.60 -3.30
Company Price Change %Gain
Indiabulls Hsg 209.95 7.67
Yes Bank 39.60 -3.30
TCS 1,987.05 -0.87
IndusInd Bank 1,223.25 -0.46
Bandhan Bank 583.40 15.08
Top Gainers
Company Price Change %Gain
Cipla 441.35 4.55
Vedanta 147.05 4.18
Infosys 814.80 4.05
Tata Motors 121.30 3.85
ONGC 129.00 2.79
Company Price Change %Gain
Infosys 815.70 4.19
Vedanta 146.95 3.96
Tata Motors 121.35 3.81
ONGC 129.10 2.95
Tata Steel 339.40 2.94
Top Losers
Company Price Change %Gain
Yes Bank 39.60 -3.30
IOC 143.40 -3.24
GAIL 124.95 -1.88
M&M 560.10 -1.05
Zee Entertain 242.50 -1.02
Company Price Change %Gain
Yes Bank 39.60 -3.30
M&M 559.80 -1.19
TCS 1,987.05 -0.87
Reliance 1,352.40 -0.73
IndusInd Bank 1,223.25 -0.46

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results